Science Daily: Pharmacology News
SEPTEMBER 30, 2024
Frequent drinking of fizzy drinks or fruit juice is associated with an increased risk of stroke, according to new findings. The research also found that drinking more than four cups of coffee per day also increases the risk of stroke.
BioPharma Drive: Drug Pricing
SEPTEMBER 30, 2024
The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
New research shows that the Vikings traveled more than 6,000 kilometers to the Arctic to hunt for walrus. DNA analyses reveal that walrus ivory from Greenland was brought to Europe and probably as far as the Middle East [M1] via extensive trade networks.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.Synthetic THC (dronabinol) also gave patients' caregivers a boost, according to findings presented.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
New findings on how past viral respiratory infections affect future, unrelated ones could lead to therapies for boosting general antiviral immunity -- and potentially pandemic preparedness.
Drug Patent Watch
SEPTEMBER 30, 2024
Patent expirations have a significant impact on the pharmaceutical industry, particularly on the generic drug market. When a drug’s patent expires, other manufacturers can produce and market generic versions of the drug, leading to increased competition and lower prices.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- One in every three girls may not have access to menstrual products, something researchers are dubbing "period poverty."“Our study highlights the widespread nature of period poverty and the need for broad actions -- both l.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
Mount Everest is about 15 to 50 meters taller than it would otherwise be because of uplift caused by a nearby eroding river gorge, and continues to grow because of it.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- More than 14 million seniors a year take a tumble, and those falls can be life-changing. "The relationship between falls and dementia appears to be a two-way street," said Molly Jarman, senior author of a new study showing.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
The Hunga Tonga underwater volcano was one of the largest volcanic eruptions in history, and now, two years later, new research has revealed its main trigger.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Broad Institute
SEPTEMBER 30, 2024
Q&A: How Terra became a backbone of public health pathogen surveillance By Allessandra DiCorato September 30, 2024 Breadcrumb Home Q&A: How Terra became a backbone of public health pathogen surveillance Bronwyn MacInnis and Daniel Park reflect on how Terra, a scalable and secure open-source platform for biomedical data management and analysis, is making genomics accessible to public health labs.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
Head-to-head study of diagnostic test accuracy found IOTA ultrasound ADNEX model had 96% sensitivity and acceptable specificity in first study of its kind.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- In what could be the first cases of bird flu spreading between humans in the United States, a group of potential H5N1 infections in Missouri has now grown to eight.Antibody tests to confirm any H5N1 infection are still.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
Data from an international space mission is confirming decades worth of speculation about the galactic neighborhoods of supermassive black holes.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- Read to your little ones.That's the American Academy of Pediatrics' (AAP) prescription for fostering loving, nurturing relationships during early infancy and early childhood -- a time of critical brain development."Reading.
Science Daily: Pharmacology News
SEPTEMBER 30, 2024
Engineers have developed an innovative way to make covalent organic frameworks, special materials that can be used to trap gases, filter water and speed up chemical reactions.
Quanticate
SEPTEMBER 30, 2024
In any clinical trial conduct, recording and storing data in a controlled, consistent, and reproducible manner for data retrieval and analysis is a necessity for regulatory compliance and clinical study success.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- Black American infants born with congenital heart disease are less likely to survive to the age of 1, compared to white babies with the condition, a new study finds.The research suggests that Black infants aren't reaping.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
thought leadership
SEPTEMBER 30, 2024
If you’re starting to explore marketing your medical device in the European Union (EU) or have a medical device that is currently CE Marked, you’re becoming familiar with the term ‘CER’ or Clinical Evaluation Report. However, do you really know what a CER is and how it evolved into the modern document required for the EU MDR (Medical Device Regulation)?
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- Toxic lead continues to pose a danger to U.S. consumers despite years of progress to reduce exposure, claims a study spanning four states."Consumer products were consistently identified as one of the main sources of lead.
BioPharma Drive: Drug Pricing
SEPTEMBER 30, 2024
The high-profile biotech is zeroing in on programs that serve as proof points for its technology, while seeking partners for other assets.
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- In a world where families may be more apt to interact with technology than with one another, some things never change.Many still struggle to get along. But just what do 21st century families fight about?A new survey of.
BioPharma Drive: Drug Pricing
SEPTEMBER 30, 2024
Among the investors in Aktis’ Series B round were Bristol Myers Squibb, Eli Lilly and Merck & Co., all of which have expanded their involvement in the radiopharma field.
Drug Target Review
SEPTEMBER 30, 2024
Compared to traditional antibody therapies, how does the precision binding approach in your antibody design impact the therapeutic window and dosing regimen in preclinical models? Our approach represents a paradigm shift. Traditional drug discovery is based on the premise that target proteins have biological functions. Drugs should shut off, or antagonise, proteins with undesirable functions.
Perficient: Drug Development
SEPTEMBER 30, 2024
Rich text editors are essential for many web applications, allowing users to format text, add links, and even insert media directly into their content. Quill.js is a powerful, customizable open-source editor that integrates seamlessly with modern frameworks like Vue.js. This tutorial will walk us through the steps to set up and integrate Quill.js in a Vue.js project to create a dynamic rich text editor.
Covalent Modifiers
SEPTEMBER 30, 2024
Elizabeth M. Ryan, Michael A. Norinskiy, Amy K. Bracken, Emma E. Lueders, Xueer Chen, Qin Fu, Elizabeth T. Anderson, Sheng Zhang, and Mikail E. Abbasov Journal of the American Chemical Society 2024 DOI: 10.1021/jacs.4c09073 Lysine acylations are ubiquitous and structurally diverse post-translational modifications that vastly expand the functional heterogeneity of the human proteome.
FDA Law Blog: Biosimilars
SEPTEMBER 30, 2024
By Alan M. Kirschenbaum & Sophia R. Gaulkin — In May 2023, we posted about a CMS proposed regulation that sought to make a wide variety of changes to the Medicaid Drug Rebate Program (MDRP), including a new “price verification survey,” and a controversial proposal to require “stacking” of discounts to different customers when determining best price.
Covalent Modifiers
SEPTEMBER 30, 2024
Alexandra Geißler, Howard Junca , Andreas M. Kany , Lena J. Daumann, Anna K. H. Hirsch Dietmar H. Pieper b and Stephan A. Sieber Chem. Sci., 2024 , 15, 11946-11955 [link] Isonitrile natural products, also known as isocyanides, demonstrate potent antimicrobial activities, yet our understanding of their molecular targets remains limited. Here, we focus on the so far neglected group of monoisonitriles to gain further insights into their antimicrobial mode of action (MoA).
Drugs.com
SEPTEMBER 30, 2024
MONDAY, Sept. 30, 2024 -- A shorter course of post-mastectomy radiation doesn't jeopardize a patient's chances of successful breast reconstruction, a new study finds.About 40 percent of people with breast cancer have mastectomies, followed by five.
Alta Sciences
SEPTEMBER 30, 2024
Accelerated Study Timelines, Less Logistical Hurdles blussier Mon, 09/30/2024 - 12:47 HTML The True Meaning of Moving in Unison We value your time as much as you do. At Altasciences, we break down organizational silos, streamline project management, and promote effortless communication to provide you with exceptional value. WATCH VIDEO From preclinical studies to clinical trials, and from regulatory submissions to tackling operational challenges, we are dedicated to safely accelerating your jour
Practical Cheminformatics
SEPTEMBER 30, 2024
This week is a special Pat substitution. Pat(rick) Riley is taking over this blog post for a follow up on our Thompson Sampling paper. In our recent paper Thompson Sampling─An Efficient Method for Searching Ultralarge Synthesis on Demand Databases we showed how you could use the classic Thompson Sampling algorithm to select each reagent in a combinatorial library to conduct an efficient search for a variety of scoring functions.
Fierce BioTech
SEPTEMBER 30, 2024
Fierce Pharma Engage Fierce Pharma Engage is where pharma and biotech executives meet to connect, collaborate, and explore custom strategies for marketing, dealmaking, medical affairs, and communications in a dynamic and intimate setting through educational sessions, structured networking and social functions that bring new ideas across marketing, commercialization and digital innovations. llam Mon, 09/30/2024 - 17:44 Resource Type Questex Event Fierce Pharma Engage Logo Color.
Perficient: Drug Development
SEPTEMBER 30, 2024
Perficient’s presence at Dreamforce 2024 was more than just attending—it was about connecting, innovating, and driving real change. From discussing cutting-edge AI like Agentforce to supporting initiatives such as Girls Who Code, Perficient is committed to shaping both the present and future of technology. Whether you joined us at our sessions or other events, we aimed to create meaningful experiences for all attendees.
Expert insights. Personalized for you.
129 
Let's personalize your content